Intranasal insulin for treatment of delirium in older hospitalised patients: study protocol for a randomised controlled trial
Introduction Delirium is one of the most common conditions diagnosed in hospitalised older people and is associated with numerous adverse outcomes, yet there are no proven pharmacological treatments. Recent research has identified cerebral glucose hypometabolism as a pathophysiological mechanism off...
Saved in:
| Main Authors: | Meera Agar, Barbara Toson, Jacqueline Close, Andrew Milne, Gideon Caplan, Anita Nitchingham, Bernard Tuch |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-10-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/11/10/e050765.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Delirium researchers' perspectives of the challenges in delirium biomarker research: A qualitative study.
by: Ingrid Amgarth-Duff, et al.
Published: (2021-01-01) -
Economic impact of delirium in Australia: a cost of illness study
by: Gideon A Caplan, et al.
Published: (2019-09-01) -
Intranasal insulin for improving cognitive function in multiple sclerosis
by: Scott D. Newsome, et al.
Published: (2025-07-01) -
Intranasal Insulin Diminishes Postoperative Delirium and Elevated Osteocalcin and Brain Derived Neurotrophic Factor in Older Patients Undergoing Joint Replacement: A Randomized, Double-Blind, Placebo-Controlled Trial
by: Yang M, et al.
Published: (2025-02-01) -
Increased Brain Glutathione Levels by Intranasal Insulin Administration
by: Taisuke Kawashima, et al.
Published: (2025-04-01)